Comparative outcomes of Thai children with acute lymphoblastic leukemia treated with two consecutive protocols: 11-year experience

References

• Pui CH, Campana D, Pei D, . Treatment of childhood acute lymphoblastic leukemia without prophylactic cranial irradiation. N Engl J Med 2009;360:2730–2741.
   PubMed Web of Science ®Google Scholar
• Pui CH. Toward a total cure for acute lymphoblastic leukemia. J Clin Oncol 2009;27:5121–5123.
   PubMed Web of Science ®Google Scholar
• Pui CH, Pei D, Sandlund JT, . Long-term results of St Jude Total Therapy Studies 11, 12, 13A, 13B, and 14 for childhood acute lymphoblastic leukemia. Leukemia 2010;24:371–382.
   PubMed Web of Science ®Google Scholar
• Möricke A, Zimmermann M, Reiter A, . Long-term results of five consecutive trials in childhood acute lymphoblastic leukemia performed by the ALL-BFM study group from 1981 to 2000. Leukemia 2010;24:265–284.
   PubMed Web of Science ®Google Scholar
• Veerman AJ, Kamps WA, van den Berg H, . Dexamethasone-based therapy for childhood acute lymphoblastic leukaemia: results of the prospective Dutch Childhood Oncology Group (DCOG) protocol ALL-9 (1997-2004). Lancet Oncol 2009;10:957–966.
   PubMed Web of Science ®Google Scholar
• Moghrabi A, Levy DE, Asselin B, . Results of the Dana-Farber Cancer Institute ALL Consortium Protocol 95-01 for children with acute lymphoblastic leukemia. Blood 2007;109:896–904.
   PubMed Web of Science ®Google Scholar
• Schultz KR, Pullen DJ, Sather HN, . Risk- and response-based classification of childhood B-precursor acute lymphoblastic leukemia: a combined analysis of prognostic markers from the Pediatric Oncology Group (POG) and Children's Cancer Group (CCG). Blood 2007;109:926–935.
   PubMed Web of Science ®Google Scholar
• Möricke A, Zimmermann M, Reiter A, . Prognostic impact of age in children and adolescents with acute lymphoblastic leukemia: data from the trials ALL-BFM 86, 90, and 95. Klin Padiatr 2005;217:310–320.
   PubMed Web of Science ®Google Scholar
• Pui CH, Campana D. Age-related differences in leukemia biology and prognosis: the paradigm of MLL-AF4-positive acute lymphoblastic leukemia. Leukemia 2007;21:593–594.
   PubMed Web of Science ®Google Scholar
• Pui CH. T cell acute lymphoblastic leukemia: NOTCHing the way toward a better treatment outcome. Cancer Cell 2009;15:85–87.
   PubMed Web of Science ®Google Scholar
• Mullighan CG. Mutations of NOTCH1, FBXW7, and prognosis in T-lineage acute lymphoblastic leukemia. Haematologica 2009;94: 1338–1340.
   PubMed Web of Science ®Google Scholar
• Pui CH, Thiel E. Central nervous system disease in hematologic malignancies: historical perspective and practical applications. Semin Oncol 2009;36:S2–S16.
   PubMed Web of Science ®Google Scholar
• Pui CH. Prophylactic cranial irradiation: going, going, gone. Lancet Oncol 2009;10:932–933.
   PubMed Web of Science ®Google Scholar
• Pui CH, . Central nervous system disease in acute lymphoblastic leukemia: prophylaxis and treatment. Hematology Am Soc Hematol Educ Program 2006:142–146.
   PubMedGoogle Scholar
• Manabe A, Ohara A, Hasegawa D, . Significance of the complete clearance of peripheral blasts after 7 days of prednisolone treatment in children with acute lymphoblastic leukemia: the Tokyo Children's Cancer Study Group Study L99–15. Haematologica 2008;93:1155–1160.
   PubMed Web of Science ®Google Scholar
• Gajjar A, Ribeiro R, Hancock ML, . Persistence of circulating blasts after 1 week of multiagent chemotherapy confers a poor prognosis in childhood acute lymphoblastic leukemia. Blood 1995;86:1292–1295.
   PubMed Web of Science ®Google Scholar
• Basso G, Veltroni M, Valsecchi MG, . Risk of relapse of childhood acute lymphoblastic leukemia is predicted by flow cytometric measurement of residual disease on day 15 bone marrow. J Clin Oncol 2009;27:5168–5174.
   PubMed Web of Science ®Google Scholar
• Sandlund JT, Harrison PL, Rivera G, . Persistence of lymphoblasts in bone marrow on day 15 and days 22 to 25 of remission induction predicts a dismal treatment outcome in children with acute lymphoblastic leukemia. Blood 2002;100:43–47.
   PubMed Web of Science ®Google Scholar
• Schultz KR, Bowman WP, Aledo A, . Improved early event-free survival with imatinib in Philadelphia chromosome-positive acute lymphoblastic leukemia: a Children's Oncology Group Study. J Clin Oncol 2009;27:5175–5181.
   PubMed Web of Science ®Google Scholar
• Pui CH, Gaynon PS, Boyett JM, . Outcome of treatment in childhood acute lymphoblastic leukaemia with rearrangements of the 11q23 chromosomal region. Lancet 2002;359:1909–1915.
   PubMed Web of Science ®Google Scholar
• Szczepański T, Harrison CJ, van Dongen JJ. Genetic aberrations in paediatric acute leukaemias and implications for management of patients. Lancet Oncol 2010;11:880–889.
   PubMed Web of Science ®Google Scholar
• Mullighan CG, Downing JR. Genome-wide profiling of genetic alterations in acute lymphoblastic leukemia: recent insights and future directions. Leukemia 2009;23:1209–1218.
   PubMed Web of Science ®Google Scholar
• Pui CH. Impact of molecular profiling and cytogenetics in acute lymphoblastic leukemia. Hematology 2005;10:176–177.
   PubMed Web of Science ®Google Scholar
• Menon J, Mathews L, Purushothaman KK. Treating leukemia in a resource poor setting. Indian Pediatr 2008;45:410–412.
   PubMed Web of Science ®Google Scholar
• Howard SC, Pedrosa M, Lins M, . Establishment of a pediatric oncology program and outcomes of childhood acute lymphoblastic leukemia in a resource-poor area. JAMA 2004;291:2471–2475.
   PubMed Web of Science ®Google Scholar
• Metzger ML, Howard SC, Fu LC, . Outcome of childhood acute lymphoblastic leukaemia in resource-poor countries. Lancet 2003;362:706–708.
   PubMed Web of Science ®Google Scholar
• Pui CH, Sandlund JT, Pei D, . Improved outcome for children with acute lymphoblastic leukemia: results of Total Therapy Study XIIIB at St Jude Children's Research Hospital. Blood 2004;104:2690–2696.
   PubMed Web of Science ®Google Scholar
• Pui CH, Relling MV, Sandlund JT, . Rationale and design of Total Therapy Study XV for newly diagnosed childhood acute lymphoblastic leukemia. Ann Hematol 2004;83:S124–S126.
   Web of Science ®Google Scholar
• Cancer Therapy Evaluation Program. Common Toxicity Criteria (CTC) version 2.0 [Internet]. Bethesda, MD: National Cancer Institute; 1999. Available from: http://ctep.cancer.gov/protocolDevelopment/electronic_applications/ctc.htm
   Google Scholar
• Campana D, Pui CH. Detection of minimal residual disease in acute leukemia: methodologic advances and clinical significance. Blood 1995;85:1416–1434.
   PubMed Web of Science ®Google Scholar
• Campana D, Coustan-Smith E. Detection of minimal residual disease in acute leukemia by flow cytometry. Cytometry 1999;38: 139–152.
   PubMedGoogle Scholar
• Coustan-Smith E, Behm FG, Sanchez J, . Immunological detection of minimal residual disease in children with acute lymphoblastic leukaemia. Lancet 1998;351:550–554.
   PubMed Web of Science ®Google Scholar
• Kalbfleisch JD, Prentice RL, . The statistical analysis of failure time data. New York: John Wiley and Sons; 1980. pp 163–188.
   Google Scholar
• Bonilla M, Moreno N, Marina N, . Acute lymphoblastic leukemia in a developing country: preliminary results of a nonrandomized clinical trial in El Salvador. J Pediatr Hematol Oncol 2000;22:495–501.
   PubMed Web of Science ®Google Scholar
• Dabbous IA, Dbouk H, Sibai AM, . Childhood acute lymphoblastic leukemia managed in tertiary care center in a developing country. Med Pediatr Oncol 2003;41:83–84.
   PubMedGoogle Scholar
• Howard SC, Pedrosa M, Lins M, . Establishment of a pediatric oncology program and outcomes of childhood acute lymphoblastic leukemia in a resource-poor area. JAMA 2004;291:2471–2475.
   PubMed Web of Science ®Google Scholar
• Hussein H, Sidhom I, Naga SA, . Outcome and prognostic factors of acute lymphoblastic leukemia in children at the National Cancer Institute, Egypt. J Pediatr Hematol Oncol 2004;26:507–514.
   PubMed Web of Science ®Google Scholar
• Halalsheh H, Abuirmeileh N, Rihani R, . Outcome of childhood acute lymphoblastic leukemia in Jordan. Pediatr Blood Cancer 2011;57:385–391.
   PubMed Web of Science ®Google Scholar
• Hughes WT, Armstrong D, Bodey GP, . 2002 Guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis 2002;34:730–751.
   PubMed Web of Science ®Google Scholar
• Pakakasama S, Surayuthpreecha K, Pandee U, . Clinical practice guideline for children with cancer presenting with fever at emergency room. Pediatr Int 2011 Mar 21. [Epub ahead of print]
   Google Scholar
• Sitaresmi MN, Mostert S, Schook R, . Treatment refusal and abandonment in childhood acute lymphoblastic leukemia in Indonesia: an analysis of causes and consequences. Psychooncology 2010;19:361–367.
   PubMed Web of Science ®Google Scholar
• Mostert S, Sitaresmi MN, Gundy CM, . Comparing childhood leukaemia treatment before and after introduction of parental education-program in Indonesia. Arch Dis Child 2010;95:20–25.
   PubMed Web of Science ®Google Scholar
• Pakakasama S, Kajanachumpol S, Kanjanapongkul S, . Simple multiplex RT-PCR for identifying common fusion transcripts in childhood acute leukemia. Int J Lab Hematol 2008;30:286–291.
   PubMed Web of Science ®Google Scholar
• Hongeng S, Sasanakul W, Chuansumrit A, . Frequency of thiopurine S-methyltransferase genetic variation in Thai children with acute leukemia. Med Pediatr Oncol 2000;35:410–414.
   PubMedGoogle Scholar
• Razzouk BI, Rose SR, Hongeng S, . Obesity in survivors of childhood acute lymphoblastic leukemia and lymphoma. J Clin Oncol 2007;25:1183–1189.
   PubMed Web of Science ®Google Scholar
• Butturini AM, Dorey FJ, Lange BJ, . Obesity and outcome in pediatric acute lymphoblastic leukemia. J Clin Oncol 2007;25: 2063–2069.
   PubMed Web of Science ®Google Scholar
• Hunter RJ, Navo MA, Thaker PH, . Dosing chemotherapy in obese patients: actual versus assigned body surface area (BSA). Cancer Treat Rev 2009;35:69–78.
   PubMed Web of Science ®Google Scholar
• Lopes-Serrao MD, Ussery SM, Hall RG II, . Evaluation of chemotherapy-induced severe myelosuppression incidence in obese patients with capped dosing. J Oncol Pract 2011;7:13–17.
   PubMedGoogle Scholar
• Field KM, Kosmider S, Jefford M, . Chemotherapy dosing strategies in the obese, elderly and thin patients: results of a nationwide survey. J Oncol Pract 2008;4:108–113.
   PubMedGoogle Scholar